OBJECTIVES: We used cluster analysis to subdivide a population of injection drug users and identify previously unknown behavioral heterogeneity within that population. METHODS: We applied cluster analysis techniques to data collected in a cross-sectional survey of injection drug users in Winnipeg, Manitoba. The clustering variables we used were based on receptive syringe sharing, ethnicity, and types of drugs injected. RESULTS: Seven clusters were identified for both male and female injection drug users. Some relationships previously revealed in our study setting, such as the known relationship between Talwin (pentazocine) and Ritalin (methylphenidate) use, injection in hotels, and hepatitis C virus prevalence, were confirmed through our cluster analysis approach. Also, relationships between drug use and infection risk not previously observed in our study setting were identified, an example being a cluster of female crystal methamphetamine users who exhibited high-risk behaviors but an absence or low prevalence of blood-borne pathogens. CONCLUSIONS: Cluster analysis was useful in both confirming relationships previously identified and identifying new ones relevant to public health research and interventions.
OBJECTIVES: We used cluster analysis to subdivide a population of injection drug users and identify previously unknown behavioral heterogeneity within that population. METHODS: We applied cluster analysis techniques to data collected in a cross-sectional survey of injection drug users in Winnipeg, Manitoba. The clustering variables we used were based on receptive syringe sharing, ethnicity, and types of drugs injected. RESULTS: Seven clusters were identified for both male and female injection drug users. Some relationships previously revealed in our study setting, such as the known relationship between Talwin (pentazocine) and Ritalin (methylphenidate) use, injection in hotels, and hepatitis C virus prevalence, were confirmed through our cluster analysis approach. Also, relationships between drug use and infection risk not previously observed in our study setting were identified, an example being a cluster of female crystal methamphetamine users who exhibited high-risk behaviors but an absence or low prevalence of blood-borne pathogens. CONCLUSIONS: Cluster analysis was useful in both confirming relationships previously identified and identifying new ones relevant to public health research and interventions.
Authors: S R Friedman; A Neaigus; B Jose; R Curtis; M Goldstein; G Ildefonso; R B Rothenberg; D C Des Jarlais Journal: Am J Public Health Date: 1997-08 Impact factor: 9.308
Authors: R H Needle; S Coyle; H Cesari; R Trotter; M Clatts; S Koester; L Price; E McLellan; A Finlinson; R N Bluthenthal; T Pierce; J Johnson; T S Jones; M Williams Journal: Subst Use Misuse Date: 1998-10 Impact factor: 2.164
Authors: D M Patrick; S A Strathdee; C P Archibald; M Ofner; K J Craib; P G Cornelisse; M T Schechter; M L Rekart; M V O'Shaughnessy Journal: Int J STD AIDS Date: 1997-07 Impact factor: 1.359
Authors: S A Strathdee; D M Patrick; C P Archibald; M Ofner; P G Cornelisse; M Rekart; M T Schechter; M V O'Shaughnessy Journal: Addiction Date: 1997-10 Impact factor: 6.526
Authors: S O Aral; J P Hughes; B Stoner; W Whittington; H H Handsfield; R M Anderson; K K Holmes Journal: Am J Public Health Date: 1999-06 Impact factor: 9.308
Authors: C P Archibald; M Ofner; S A Strathdee; D M Patrick; D Sutherland; M L Rekart; M T Schechter; M V O'Shaughnessy Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1998-02-01
Authors: Harold D Green; Joan S Tucker; Suzanne L Wenzel; Daniela Golinelli; David P Kennedy; Gery W Ryan; Annie J Zhou Journal: Child Abuse Negl Date: 2012-01-20
Authors: Mark J Ferris; Erin S Calipari; Yolanda Mateo; James R Melchior; David C S Roberts; Sara R Jones Journal: Neuropsychopharmacology Date: 2012-03-07 Impact factor: 7.853
Authors: W Susan Cheng; Richard S Garfein; Shirley J Semple; Steffanie A Strathdee; James K Zians; Thomas L Patterson Journal: J Psychoactive Drugs Date: 2010-03